Medicenna’s corporate headquarters are located in Toronto, Ontario. Medicenna’s wholly owned subsidiary, Medicenna Biopharma Inc. is located in Houston, Texas.
Medicenna’s shares began trading on the TSX Venture Exchange (TSX-V) on 03.08.2017. The Company went public via a reverse-takeover transaction at a price of $2.00 per share.
Medicenna’s shares trade on the TSX Venture Exchange (TSX-V) under the symbol "MDNA".
Medicenna’s shares can be purchased through a stockbroker, bank, or a financial institution that provides brokerage services.
Medicenna’s fiscal year end is March 31
Medicenna’s Independent Registered Public Accounting Firm is Davidson and Company LLP.
Medicenna’s transfer agent is TSX Trust Company.
Contact Medicenna’s transfer agent, TSX Trust Company at 1 866 393-4891 or TMXEInvestorServices@tmx.com
Medicenna’s Chief Financial Officer at firstname.lastname@example.org
Medicenna’s SEDAR filings can be found at www.sedar.com
You may sign up for email alerts here
For more investor information, Please contact:
Elizabeth Williams, Chief Financial Officer